UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - KINNATE BIOPHARMA INC ownership

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q1 2022$136,584,00012,1300.00%
Other shareholders

There were no reported owners of KINNATE BIOPHARMA INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of KINNATE BIOPHARMA INC shareholders